MEDICATION DEFERRAL LIST Please tell us if you are now taking or if you have EVER taken any of these medications:
Proscar (finasteride) usually given for prostate gland enlargement
Avodart, Jalyn (dutasteride) usually given for prostate enlargement
Propecia (finasteride) usually given for baldness
Accutane (Amnesteem, Claravis, Sotret, isotretinoin) usually given for severe acne
Soriatane (acitretin) – usually given for severe psoriasis
Tegison (etretinate) – usually given for severe psoriasis
Growth Hormone from Human Pituitary Glands used usually for children with delayed or impaired
Insulin from Cows (Bovine, or Beef, Insulin) used to treat diabetes
Hepatitis B Immune Globulin – given following an exposure to hepatitis B.
NOTE: This is different from the hepatitis B vaccine which is a series of 3 injections given over a
6 month period to prevent future infection from exposures to hepatitis B.
Plavix (clopidogrel) and Ticlid (ticlopidine) – inhibits platelet function; used to reduce the chance for
Feldene – given for mild to moderate arthritis pain
Experimental Medication or Unlicensed (Experimental) Vaccine – usually associated with a research protocol
IF YOU WOULD LIKE TO KNOW WHY THESE MEDICINES AFFECT YOU AS A BLOOD DONOR, PLEASE KEEP READING:
If you have taken or are taking Proscar, Avodart, Jalyn, Propecia, Accutane, Soriatane, or Tegison,
these medications can cause birth defects. Your donated blood could contain high enough levels to damage the unborn baby if transfused to a pregnant woman. Once the medication has been cleared from your blood, you may donate again. Following the last dose, the deferral period is one month Proscar, Propecia and Accutane, six months for Avodart and Jalyn, and three years for Soriatane. Tegison is a permanent deferral.
Growth hormone from human pituitary glands was prescribed for children with delayed or impaired
growth. The hormone was obtained from human pituitary glands, which are found in the brain. Some people who took this hormone developed a rare nervous system condition called Creutzfeldt-Jakob Disease (CJD, for short). The deferral is permanent.
Insulin from cows (bovine, or beef, insulin) is an injected material used to treat diabetes. If this insulin
was imported into the US from countries in which “Mad Cow Disease” has been found, it could contain material from infected cattle. There is concern that "Mad Cow Disease" is transmitted by transfusion. The deferral is indefinite.
Hepatitis B Immune Globulin (HBIG) is an injected material used to prevent infection following an
exposure to hepatitis B. HBIG does not prevent hepatitis B infection in every case, therefore persons who have received HBIG must wait 12 months to donate blood to be sure they were not infected since hepatitis B can be transmitted through transfusion to a patient.
MEDICATION DEFERRAL LIST CONTINUES ON BACK OF THIS FORM. PLEASE SEE OTHER SIDE MEDICATION DEFERRAL LIST
Feldene is a non-steroidal anti-inflammatory drug that can affect platelet function. A donor taking Feldene
will not be able to donate platelets for 2 days; however, its use will not affect whole blood donations.
Plavix and Ticlid are medications that can decrease the chance of a heart attack or stroke in individuals at
risk for these conditions. Since these medications can affect platelets, anyone taking Plavix or Ticlid will not be able to donate platelets for 14 days after the last dose. Use of either medication will not prohibit whole blood donations.
Experimental Medication or Unlicensed (Experimental) Vaccine is usually associated with a research
protocol and the effect on blood donation is unknown. Deferral is one year unless otherwise indicated by Medical Director.
DHQ v. 1.3 eff. May 2008 (rev. Sept 2010)
Please tell us if you are now taking or if you have EVER taken any of these medications:
Absorica (isotretinoin) – usually given for severe acne
Arava (Leflunomide) – used to treat patients with rheumatoid arthritis
Avolve (Dutasteride) usually given for prostate enlargement
MethotrexateorMercaptopurine – given for malignancy or active rheumatoid arthritis
Coumadin, Warfilone, Jantoven (Warfarin) – usually given to prevent normal blood clotting
Arixtra (Fondaparinux) – usually given to prevent normal blood clotting
Fragmin (dalteparin) – usually given to prevent normal blood clotting
Lovenox (enoxaparin) – usually given to prevent normal blood clotting
Pradaxa (Dabigatron) – blood thinner used to treat patients with atrial fibrillation
Heparin or Heparin Derivatives – usually given to prevent normal blood clotting
Direct Xa Inhibitors (e.g., Rivaroxaban, Xarelto) – usually given to prevent normal blood clotting
Roaccutane – usually given for severe acne ADDITIONAL MEDICATIONS DEFERRAL LIST FOR PLATELET APHERESIS DONORS ONLY Please tell us if you are now taking or if you have EVER taken any of these medications:
Although these medications are used for a variety of reasons they all affect the ability of platelets to participate in the body’s blood clotting mechanism. These medications make your platelets less effective in preventing or stopping bleeding in a patient who is not able to make platelets for him/herself. Aspirin and Nonsteroidal anti-inflammatory drugs are present in a wide variety of prescription and over the counter medications and have a bewildering variety of names that often provides no clue to what the medication does or does not contain. If you are not sure about a medication that you are taking please inform the blood center historian who has lists of product names for these very common medications.
MEDICATION DEFERRAL LIST CONTINUES ON BACK OF THIS FORM. PLEASE SEE OTHER SIDE
PC - ESOMEPRAZOLE 40mg Composition Each enteric coated tablet contains: Esomeprazole 40mg Description Esomeprazole magnesium is bis(5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl] sulfinyl]-1H-benzimidazole-1-yl) magnesium trihydrate, a compound that inhibits gastric acid secretion. Esomeprazole is the S-isomer of omeprazole, which is a mixture of the S- and R-
Open access, freely available online Policy Forum The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers Robert Cockburn ☯ *, Paul N. Newton ☯ , E. Kyeremateng Agyarko, Dora Akunyili, Nicholas J. White Introduction loss of public conﬁ dence in medicines counterfeit drugs to the FDA within ﬁ ve days of discovery (see “Comp